Raquel Herrero

1.1k citations

31 papers · 760 indexed · h-index 17

Co-authors: José A. Lorente Gustavo Matute‐Bello Laura Moreno Thomas R. Martin Antonio Artigas Raquel Guillamat‐Prats Ferranda Puig Javier Vaquero
Topics: Neonatal Respiratory Health Research (13 papers)Respiratory Support and Mechanisms (12 papers)Immune Response and Inflammation (7 papers)
Cited by: Critical Care and Intensive Care Medicine Pulmonary and Respiratory Medicine Immunology
Journals: Journal of Clinical Investigation The Journal of Immunology Gastroenterology
Partner nations: Spain United States Canada

In The Last Decade

Raquel Herrero

28 papers receiving 756 citations

Peers

Countries citing papers authored by Raquel Herrero

Since Specialization

Citations

This map shows the geographic impact of Raquel Herrero's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raquel Herrero with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raquel Herrero more than expected).

Fields of papers citing papers by Raquel Herrero

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raquel Herrero. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raquel Herrero. The network helps show where Raquel Herrero may publish in the future.

Co-authorship network of co-authors of Raquel Herrero

This figure shows the co-authorship network connecting the top 25 collaborators of Raquel Herrero. A scholar is included among the top collaborators of Raquel Herrero based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Raquel Herrero. Raquel Herrero is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Preclinical evaluation of several polymeric micelles identifies Soluplus®-docetaxel as the most effective candidate in multiple glioblastoma models 2025 ·Journal of Controlled Release ·(unknown),Raquel Herrero,(unknown),(unknown),(unknown),(unknown),Sergi Sabaté,(unknown),(unknown),Belén Prieto García,(unknown),Zamira V. Díaz‐Riascos,Cláudia Martins,Simó Schwartz,(unknown),Ibane Abasolo,Pilar Sánchez‐Gómez,Bruno Sarmento,Diana Rafael,Fernanda Atanaena Gonçalves de Andrade	1
2	Cilastatin Attenuates Acute Kidney Injury and Reduces Mortality in a Rat Model of Sepsis 2025 ·International Journal of Molecular Sciences ·(unknown),Blanca Humanes,Raquel Herrero,(unknown),Beatriz López‐Manzanares,Antonio Ferruelo,José A. Lorente,Alberto Lázaro	0
3	New insights in ARDS pathogenesis 2022 ·Signa Vitae ·(unknown),Raquel Herrero,(unknown),José A. Lorente,(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown)	0
4	SARS-CoV-2 Infection Triggers Auto-Immune Response in ARDS 2022 ·Frontiers in Immunology ·Pablo Juanes‐Velasco,Alicia Landeira‐Viñuela,(unknown),Quentin Lécrevisse,Raquel Herrero,Antonio Ferruelo,Rafael Góngora,Fernando J. Corrales,Javier De Las Rivas,José A. Lorente,(unknown),Manuel Fuentes	16
5	The bioactivity of soluble Fas ligand is modulated by key amino acids of its stalk region 2021 ·PLoS ONE ·Osamu Kajikawa,Raquel Herrero,Yu‐Hua Chow,Chi F. Hung,Gustavo Matute‐Bello	4
6	Metabolomic diferences between COVID-19 and H1N1 influenza induced ARDS 2021 ·Critical Care ·José A. Lorente,Nicolás Nín,Palmira Villa,(unknown),(unknown),Ignacio Rodríguez,Raquel Herrero,Óscar Peñuelas,Jesús Ruı́z-Cabello,José Luis Izquierdo-García	23
7	Serum MicroRNAs as Biomarkers of Sepsis and Resuscitation 2021 ·Applied Sciences ·(unknown),Antonio Ferruelo,Nicolás Nín,(unknown),Marta de Paula,Rachele Pandolfi,Laura Moreno,Raquel Herrero,(unknown),Óscar Peñuelas,Francisco Pérez‐Vizcaíno,José A. Lorente	1
8	Mesenchymal stromal/stem cells modulate response to experimental sepsis-induced lung injury via regulation of miR-27a-5p in recipient mice 2020 ·Thorax ·(unknown),(unknown),Hajera Amatullah,Shirley H. J. Mei,Raquel Herrero,José A. Lorente,Duncan J. Stewart,Philip A. Marsden,W. Conrad Liles,Pingzhao Hu,Claúdia C. dos Santos	23
9	Histopathological changes of organ dysfunction in sepsis 2019 ·Intensive Care Medicine Experimental ·Antonio Garofalo,(unknown),(unknown),Demetrio Carriedo,(unknown),(unknown),Óscar Peñuelas,Raquel Herrero,(unknown),José A. Lorente	55
10	New insights into the mechanisms of pulmonary edema in acute lung injury 2018 ·Annals of Translational Medicine ·Raquel Herrero,(unknown),José A. Lorente	188
11	Fas activation alters tight junction proteins in acute lung injury 2018 ·Thorax ·Raquel Herrero,(unknown),Antonio Ferruelo,Ferranda Puig,Rachele Pandolfi,Raquel Guillamat‐Prats,Laura Moreno,Gustavo Matute‐Bello,Antonio Artigas,Martin Dres,José A. Lorente	37
12	Intratracheal instillation of alveolar type II cells enhances recovery from acute lung injury in rats 2017 ·The Journal of Heart and Lung Transplantation ·Raquel Guillamat‐Prats,Ferranda Puig,Marta Camprubí–Rimblas,Raquel Herrero,Anna Serrano‐Mollar,(unknown),(unknown),Michael A. Matthay,Lluís Blanch,Antonio Artigas	29
13	A new experimental model of acid- and endotoxin-induced acute lung injury in rats 2016 ·American Journal of Physiology-Lung Cellular and Molecular Physiology ·Ferranda Puig,Raquel Herrero,Raquel Guillamat‐Prats,(unknown),(unknown),Laura Chimenti,(unknown),Lluís Blanch,Anna Serrano‐Mollar,(unknown),Antonio Artigas	23
14	Selective Digestive Decontamination Attenuates Organ Dysfunction in Critically Ill Burn Patients 2016 ·Shock ·Lucía López‐Rodríguez,Miguel A. de la Cal,P. García-Hierro,Raquel Herrero,Judith Martins,H. K. F. van Saene,José A. Lorente	9
15	The biological activity of FasL in human and mouse lungs is determined by the structure of its stalk region 2011 ·Journal of Clinical Investigation ·Raquel Herrero,Osamu Kajikawa,Gustavo Matute‐Bello,Yi Wang,Naoki Hagimoto,(unknown),Venus Wong,David R. Park,Nathan Brot,Jay W. Heinecke,Henry Rosen,Richard B. Goodman,Xiaoyun Fu,Thomas R. Martin	48
16	Fas Activation in Alveolar Epithelial Cells Induces KC (CXCL1) Release by a MyD88-Dependent Mechanism 2011 ·American Journal of Respiratory Cell and Molecular Biology ·(unknown),Alison J. Eastman,Raquel Herrero,Josiah F. Hanson,(unknown),William A. Altemeier,Gustavo Matute‐Bello	25
17	Use of infliximab in an idiopathic retinal vasculitis refractory to conventional immunosuppressive therapy 2011 ·European Journal of Ophthalmology ·(unknown),(unknown),(unknown),Raquel Herrero	1
18	Febrile-Range Hyperthermia Augments Lipopolysaccharide-Induced Lung Injury by a Mechanism of Enhanced Alveolar Epithelial Apoptosis 2010 ·The Journal of Immunology ·(unknown),Gustavo Matute‐Bello,Raquel Herrero,Kiyoyasu Kurahashi,Venus A. Wong,Stephen M. Mongovin,Thomas R. Martin	35
19	Glutamate transporter EAAT4 is increased in hippocampal astrocytes following lateral fluid-percussion injury in the rat 2007 ·Brain Research ·Jae‐Hyuk Yi,Raquel Herrero,Gang Chen,Alan S. Hazell	15
20	Mild Hypothermia Attenuates Liver Injury and Improves Survival in Mice With Acetaminophen Toxicity 2006 ·Gastroenterology ·Javier Vaquero,Mireille Bélanger,Laura P. James,Raquel Herrero,Paul Desjardins,Jean Côté,Andrés T. Blei,Roger F. Butterworth	58

About Raquel Herrero

Raquel Herrero is a scholar working on Critical Care and Intensive Care Medicine, Pulmonary and Respiratory Medicine and Nephrology, having authored 31 papers that have together received 760 indexed citations. Recurring topics across this work include Neonatal Respiratory Health Research (13 papers), Respiratory Support and Mechanisms (12 papers) and Immune Response and Inflammation (7 papers). The work is most often cited by research in Critical Care and Intensive Care Medicine (73 citations), Pulmonary and Respiratory Medicine (266 citations) and Immunology (161 citations). Raquel Herrero has collaborated with scholars based in Spain, United States and Canada. Frequent co-authors include José A. Lorente, Gustavo Matute‐Bello, Laura Moreno, Thomas R. Martin, Antonio Artigas, Raquel Guillamat‐Prats, Ferranda Puig, Javier Vaquero, Venus A. Wong and Antonio Ferruelo. Their work appears in journals such as Journal of Clinical Investigation, The Journal of Immunology and Gastroenterology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact